CIENCIASMEDICASNEWS: Medical News | Medical Articles: Exosome characterization with FFF-MALS

martes, 30 de julio de 2019

Medical News | Medical Articles: Exosome characterization with FFF-MALS

	July 30, 2019
	Nanomedicine
	The latest nanomedicine news from News Medical

Exosomecharacterization with FFF-MALS

FFF-MALS combines isolation of exosomes from other matrix components with online determination of size and composition. Fractions can be collected for off-line genomic, proteomic and lipidomic analysis.

Find Out More

			Nanoparticles used to deliver CRISPR gene editing tools into the cell Researchers from Tufts University and the Chinese Academy of Sciences have developed a novel method to effectively deliver the CRISPR/Cas9 (clustered regularly interspaced short palindromic repeat (CRISPR) associated protein 9) gene editing tools into the liver for genetic studies.

			An injection of nanoparticles for spinal cord injuries Researchers from the University of Michigan used nanopaticles injection to prevent the immune cells of the body from impairing the healing of injured brain and spinal cord. They call this an “EpiPen” or emergency rescue drug for the brain and spinal cord when they suffer trauma.

	Researchers exploit nanoparticles to develop test for early detection of different diseases Investigators from Brigham and Women's Hospital are taking advantage of a unique phenomenon of nanoparticles to develop a test for early detection of different types of diseases, including cancer.

	Nanoparticles foster regenerative healing process after spinal cord injury Paralyzing damage in spinal cord injury is often caused by the zealous immune response to the injury. NIBIB-funded engineers have developed nanoparticles that lure immune cells away from the spinal cord, allowing regeneration that restored spinal cord function in mice.

	Nanotechnology-based compound used to deliver hepatitis B vaccine Nanotechnology-based compounds are now being tested as a possible delivery vehicle for vaccines. A team of researchers demonstrated how the oral delivery vehicle SBA-15, one such nanotechnology-based compound can deliver an oral vaccine against hepatitis B to the immune system.